Syntegon looks back on a Stable Business Development in 2022. Thanks to its proven machinery and service portfolio, innovative powers, and global footprint with 37 sites in 20 countries, the company increased both order income and sales last year despite the persistent challenges of the global supply chain crisis. Order income rose by 3.0 percent […]

The post Syntegon with stable business development in 2022 first appeared on World Pharma Today.